Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $27.43 (+1.93%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 21, 2025 | David Amsellem | Piper Sandler | $32.00 | +16.7% |
| Aug 8, 2024 | David Amsellem | Piper Sandler | $66.00 | +140.6% |
| May 23, 2024 | David Amsellem | Piper Sandler | $71.00 | +158.8% |
| Mar 12, 2022 | David Amsellem | Piper Sandler | $35.00 | +27.6% |
Top Analysts Covering AMPH
AMPH vs Sector & Market
| Metric | AMPH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.12 | 2.25 | 2.41 |
| Analyst Count | 8 | 8 | 19 |
| Target Upside | -23.4% | +153002.0% | +21.5% |
| P/E Ratio | 16.52 | 3.45 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $190M | $197M | $205M | 3 |
| 2027-03-31 | $175M | $182M | $189M | 3 |
| 2027-06-30 | $182M | $188M | $196M | 2 |
| 2027-09-30 | $199M | $206M | $214M | 2 |
| 2027-12-31 | $203M | $210M | $218M | 3 |
| 2028-12-31 | $824M | $824M | $824M | 5 |
| 2029-12-31 | $863M | $881M | $897M | 2 |
| 2030-12-31 | $886M | $905M | $922M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.79 | $0.83 | $0.87 | 2 |
| 2027-03-31 | $0.72 | $0.75 | $0.79 | 2 |
| 2027-06-30 | $0.75 | $0.79 | $0.83 | 1 |
| 2027-09-30 | $0.87 | $0.91 | $0.96 | 1 |
| 2027-12-31 | $0.81 | $0.85 | $0.89 | 2 |
| 2028-12-31 | $3.51 | $3.61 | $3.69 | 1 |
| 2029-12-31 | $2.94 | $3.02 | $3.09 | 1 |
| 2030-12-31 | $2.92 | $3.00 | $3.07 | 1 |
Frequently Asked Questions
What is the analyst consensus for AMPH?
The consensus among 8 analysts covering Amphastar Pharmaceuticals, Inc. (AMPH) is Hold with an average price target of $21.25.
What is the highest price target for AMPH?
The highest price target for AMPH is $71.00, set by David Amsellem at Piper Sandler on 2024-05-23.
What is the lowest price target for AMPH?
The lowest price target for AMPH is $32.00, set by David Amsellem at Piper Sandler on 2025-03-21.
How many analysts cover AMPH?
8 analysts have issued ratings for Amphastar Pharmaceuticals, Inc. in the past 12 months.
Is AMPH a buy or sell right now?
Based on 8 analyst ratings, AMPH has a consensus rating of Hold (3.12/5) with a -23.4% upside to the consensus target of $21.25.
What are the earnings estimates for AMPH?
Analysts estimate AMPH will report EPS of $0.83 for the period ending 2026-12-31, with revenue estimated at $197M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.